Check-Cap Ltd. (CHEK) Analysts See $-0.14 EPS; Allegheny Technologies (ATI) Covered By 8 Bullish Analysts Last Week

February 13, 2018 - By Hazel Jackson

Among 13 analysts covering Allegheny Tech (NYSE:ATI), 8 have Buy rating, 0 Sell and 5 Hold. Therefore 62% are positive. Allegheny Tech had 39 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was upgraded by Cowen & Co to “Outperform” on Monday, January 8. The rating was maintained by Buckingham Research on Friday, January 26 with “Buy”. Deutsche Bank upgraded Allegheny Technologies Incorporated (NYSE:ATI) on Monday, October 5 to “Buy” rating. As per Wednesday, October 11, the company rating was maintained by KeyBanc Capital Markets. Cowen & Co maintained Allegheny Technologies Incorporated (NYSE:ATI) on Tuesday, July 25 with “Hold” rating. Stifel Nicolaus maintained Allegheny Technologies Incorporated (NYSE:ATI) on Thursday, October 1 with “Buy” rating. As per Tuesday, October 20, the company rating was downgraded by Bank of America. Bank of America upgraded Allegheny Technologies Incorporated (NYSE:ATI) on Monday, May 23 to “Buy” rating. Cowen & Co maintained it with “Market Perform” rating and $23 target in Thursday, September 3 report. KeyBanc Capital Markets maintained the shares of ATI in report on Thursday, November 16 with “Hold” rating. See Allegheny Technologies Incorporated (NYSE:ATI) latest ratings:

26/01/2018 Broker: Buckingham Research Old Rating: Buy New Rating: Buy Old Target: $30 New Target: $40 Maintain
24/01/2018 Broker: JP Morgan Old Rating: Neutral New Rating: Neutral Old Target: $18 New Target: $25 Maintain
24/01/2018 Broker: Bank of America Old Rating: Buy New Rating: Neutral Downgrade
22/01/2018 Broker: Seaport Global Rating: Buy New Target: $35.0 Maintain
08/01/2018 Broker: Cowen & Co Old Rating: Market Perform New Rating: Outperform Upgrade
16/11/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
18/10/2017 Broker: Berenberg Rating: Hold New Target: $17.2
11/10/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
11/09/2017 Broker: Bank of America Old Rating: Underperform New Rating: Buy Upgrade

Analysts expect Check-Cap Ltd. (NASDAQ:CHEK) to report $-0.14 EPS on March, 8.They anticipate $0.01 EPS change or 6.67% from last quarter’s $-0.15 EPS. After having $-0.13 EPS previously, Check-Cap Ltd.’s analysts see 7.69% EPS growth. The stock decreased 1.31% or $0.0098 during the last trading session, reaching $0.7401. About 18,532 shares traded. Check-Cap Ltd. (NASDAQ:CHEK) has declined 2.26% since February 13, 2017 and is downtrending. It has underperformed by 18.96% the S&P500.

Among 4 analysts covering Check-Cap (NASDAQ:CHEK), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Check-Cap had 11 analyst reports since July 22, 2015 according to SRatingsIntel. The rating was maintained by H.C. Wainwright with “Buy” on Thursday, September 28. The stock has “Buy” rating by H.C. Wainwright on Friday, August 11. The stock of Check-Cap Ltd. (NASDAQ:CHEK) has “Buy” rating given on Thursday, January 19 by Rodman & Renshaw. The rating was maintained by Maxim Group with “Buy” on Tuesday, May 30. Chardan Capital Markets maintained Check-Cap Ltd. (NASDAQ:CHEK) on Wednesday, March 16 with “Buy” rating. The rating was maintained by Chardan Capital Markets with “Buy” on Wednesday, July 22. H.C. Wainwright maintained Check-Cap Ltd. (NASDAQ:CHEK) rating on Tuesday, November 28. H.C. Wainwright has “Buy” rating and $5.5 target. The firm earned “Buy” rating on Friday, May 20 by Chardan Capital Markets. The stock of Check-Cap Ltd. (NASDAQ:CHEK) has “Buy” rating given on Thursday, January 11 by H.C. Wainwright. The firm earned “Buy” rating on Thursday, October 8 by Maxim Group.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of an ingestible imaging capsule that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers. The company has market cap of $14.26 million. The Company’s C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit that is designed to track the capsule and record imaging and positioning data; and C-Scan View, a personal computer software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface. It currently has negative earnings.

Allegheny Technologies Incorporated produces and sells specialty materials and components worldwide. The company has market cap of $3.41 billion. The firm operates through two divisions, High Performance Materials & Components; and Flat-Rolled Products. It currently has negative earnings. The High Performance Materials & Components segment provides various high performance materials, including titanium and titanium alloys; nickel-and cobalt alloys and superalloys; zirconium and related alloys, such as hafnium and niobium, advanced powder alloys, and other specialty materials, in long product forms of ingots, billets, bars, rods, wires, shapes and rectangles, and seamless tubes, plus precision forgings, castings, components, and machined parts.

The stock increased 1.61% or $0.43 during the last trading session, reaching $27.06. About 135,985 shares traded. Allegheny Technologies Incorporated (NYSE:ATI) has risen 40.09% since February 13, 2017 and is uptrending. It has outperformed by 23.39% the S&P500.

Investors sentiment decreased to 0.86 in 2017 Q3. Its down 0.71, from 1.57 in 2017Q2. It fall, as 28 investors sold Allegheny Technologies Incorporated shares while 87 reduced holdings. 44 funds opened positions while 55 raised stakes. 116.44 million shares or 0.85% less from 117.44 million shares in 2017Q2 were reported. Moreover, Advisor Ltd Liability has 0.05% invested in Allegheny Technologies Incorporated (NYSE:ATI). Teachers Retirement Of The State Of Kentucky holds 17,150 shares. The Connecticut-based Lapides Asset Mngmt has invested 1.52% in Allegheny Technologies Incorporated (NYSE:ATI). Boston Prtn has 440,260 shares for 0.01% of their portfolio. Northwestern Mutual Wealth Mngmt owns 1,218 shares for 0% of their portfolio. Advsrs Asset Inc owns 41,036 shares for 0.02% of their portfolio. 12,194 were accumulated by Wellington Mgmt Group Ltd Liability Partnership. Oarsman Cap has 243,063 shares. Trexquant Inv Limited Partnership holds 0.12% or 20,286 shares. Thompson Davis Inc reported 276 shares or 0.01% of all its holdings. Truenorth Inc owns 71,390 shares for 0.79% of their portfolio. Massachusetts-based Panagora Asset has invested 0% in Allegheny Technologies Incorporated (NYSE:ATI). Geode Cap Ltd stated it has 890,714 shares. Ing Groep Nv accumulated 13,335 shares or 0.01% of the stock. Hsbc Holdg Public Limited Company invested 0% in Allegheny Technologies Incorporated (NYSE:ATI).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts